Biotechnology News and Research

RSS

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Amgen and Allergan plc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 215, a biosimilar candidate to Avastin (bevacizumab).

16 Nov 2016

New webinar provides opportunity to learn background of MicroScale Thermophoresis

Live Webinar for Users and Interested Scientists

16 Nov 2016

Photoimmunotherapy may be promising treatment option to combat cancer

When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she's describing a Tom Clancy military espionage novel.

15 Nov 2016

Igenomix rewarded accreditation by CAP in Dubai for high quality of genetic testing services

Igenomix has recently been rewarded accreditation by College of American Pathologists in Dubai, given its state-of-the-art facilities and cutting-edge products in the space of advanced reproductive genetics.

14 Nov 2016

Research to assess safety and effectiveness of stem cells as potential treatment for heart failure

Stem cells are being tested at the Medical University of South Carolina as a possible treatment for heart failure with a preserved ejection fraction, or HFpEF. The condition causes severe disability and kills half its victims within five years.

11 Nov 2016

Research reveals mechanism behind progression of neurodegenerative diseases in the brain

Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer's to spread through the brain.

9 Nov 2016

UCL research finds mismatched light and temperature levels can break down body clock function

Body clock function can break down when light and temperature levels throughout the day are out of sync, finds new UCL research in fruit flies.

8 Nov 2016

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.

8 Nov 2016

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist and cancer researcher Robert L. Harrod has been awarded a $436,500 grant from the National Cancer Institute to further his lab's research into how certain viruses cause cancers in humans.

8 Nov 2016

Characteristics of brain tumour provide insight into survival, treatment options for patients over 70

Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment options for brain tumour patients over the age of 70, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.

7 Nov 2016

Group of circulating tumour cells in the blood linked to prostate cancer spread

Researchers have found a group of circulating tumour cells in prostate cancer patient blood samples which are linked to the spread of the disease, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.

7 Nov 2016

Scientists unravel viral molecular strategies to counter mammalian immune system

As mammals evolve, so do mammalian viruses. In doing so, they develop creative and effective ways to counter and evade the antiviral responses of their mammal hosts' immune systems.

7 Nov 2016

Researchers create detailed blueprint of how the body transports zinc to maintain good health

Zinc is essential for wound healing, for vision, for DNA creation, for our senses of taste and smell, even for sexual health. But despite its importance, scientists have never fully understood the mechanism that moves the mineral through the body - until now.

7 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

Scientists develop new molecular method for detecting parasite in ham that causes toxoplasmosis

Scientists from the universities of Granada and Valencia have developed a new molecular method for determining the presence of the parasite Toxoplasma gondii, which causes toxoplasmosis, in samples of ham.

7 Nov 2016

Smoking causes added mutations in DNA of lung cells

A paper published today in Science shows that smoking tobacco causes added mutations in the DNA of lung cells and in the DNA of other cells in the body. This is the first study to show the process by which smoking causes these cancers.

4 Nov 2016

American children continue to consume sodium at high levels

Cardiovascular disease, including heart disease and stroke, kills more than 800,000 Americans each year. We know that too much salt may contribute to high blood pressure and increased cardiovascular risk.

4 Nov 2016

C-Path, CDISC and TransCelerate announce availability of TA Standard for Kidney Transplantation

The Clinical Data Interchange Standards Consortium, Critical Path Institute, and TransCelerate BioPharma, Inc., announce the open availability of a CDISC Therapeutic Area (TA) Standard for Kidney Transplantation.

3 Nov 2016

Takara Bio to provide SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing to Allen Institute

Takara Bio USA, Inc. announced today that its SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing has been selected for the development of gene expression profiles of individual brain cells as part of the Allen Cell Types Database, a public resource available from the Allen Institute for Brain Science.

2 Nov 2016

TPU scientists developing bioactive coating for medical implants

A group of young scientists from Tomsk Polytechnic University are developing a bioactive coating for medical implants. Due to its properties, it will be able to "convince" the body not to reject the artificial bones and joints.

2 Nov 2016

Biotechnology News and Research

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

New webinar provides opportunity to learn background of MicroScale Thermophoresis

Photoimmunotherapy may be promising treatment option to combat cancer

Igenomix rewarded accreditation by CAP in Dubai for high quality of genetic testing services

Research to assess safety and effectiveness of stem cells as potential treatment for heart failure

Research reveals mechanism behind progression of neurodegenerative diseases in the brain

UCL research finds mismatched light and temperature levels can break down body clock function

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

Characteristics of brain tumour provide insight into survival, treatment options for patients over 70

Group of circulating tumour cells in the blood linked to prostate cancer spread

Scientists unravel viral molecular strategies to counter mammalian immune system

Researchers create detailed blueprint of how the body transports zinc to maintain good health

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Scientists develop new molecular method for detecting parasite in ham that causes toxoplasmosis

Smoking causes added mutations in DNA of lung cells

American children continue to consume sodium at high levels

C-Path, CDISC and TransCelerate announce availability of TA Standard for Kidney Transplantation

Takara Bio to provide SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing to Allen Institute

TPU scientists developing bioactive coating for medical implants

Biotechnology eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News